But I think, indeed, the point is, I believe, that the more you increase competition in the generic drug market, the better it is, normally, for the affordability of and access to the drugs. If Canada were to play a role in that and could thereby help lower the cost further, that would be very welcome.
On October 27th, 2011. See this statement in context.